Please login to the form below

Not currently logged in
Email:
Password:

ZPB Associates acquires PR specialist Journalista

Agencies have previously worked together on a number of campaigns

ZPB Journalista

Holly Sutton, Journalista CEO (pictured left) and Zoe Bedford, CEO of ZPB Associates (pictured right)

ZPB Associates, a healthcare strategy and communications firm, has acquired Journalista to expand its PR offering.

Both agencies have been established for over ten years and have previously worked together to deliver a number of award winning campaigns.

The acquisition will combine Journalista’s offerings, which includes Healthcare UK, Big White Wall and Enterprise Research Centre, alongside ZPB’s clients. This includes Novartis, Amazon Web Services and Push Doctor.

“ZPB and Journalista operate in similar spaces, with shared values, mutually supportive services and a vision for making complex issues clearer for people across health and social care, research and digital,” said Holly Sutton, Journalista CEO and founder.

“Becoming part of ZPB means we can offer a stronger proposition to compete for the opportunities arising in the fusion of health and social care, research and digital,” she added.

The aim of the acquisition is to extend the combined reach of each company into research, digital health and pharma. When combined, the teams have previously worked for NHS England, health regulators, pharma companies, key sector media, hospital trusts and data firms.

The acquisition of Journalista provides ZPB with further expansion as part of an ongoing strategic growth programme, which was launched earlier this year.

“We know that clients prefer independent, highly-specialised consultancies like ZPB and Journalista, so this allows the two businesses to remain independent while having a bigger team with more resource to compete with some of the larger players,” said Zoe Bedford, ZPB Associates founder and CEO.

13th November 2019

From: Marketing

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
M3 (EU)

M3 was founded in 2000 with the goal of changing the world of medicine through making full use of the...

Latest intelligence

DEMAND DIVERSITY REPORT 02: Why is the LGBTQ+ community facing poorer health outcomes due to COVID-19?
We’re all aware that clinical trials have been discussed more widely since the COVID-19 pandemic. While that’s a great thing for raising awareness of clinical trials in general, it’s also...
CHECKLIST 04: Let’s make your patient recruitment strategies a success
From how to generate insights to define your audience to drilling down those all-important key messages, our checklist has everything you need to think of, covered....
Multichannel engagement and the need for greater understanding of European markets
By Laurence Olding and Georgina James...

Infographics